Lilly Hires CordenPharma to Make Mounjaro; Diamyd Booster Results
Here is a brief preview of this blast: Two cardiometabolic-related news items have been observed: Lilly has reportedly hired CordenPharma to produce Mounjaro (view article); and Diamyd Medical announced preliminary results from DIAGNODE-B which provided additional support for the safety and feasibility of booster injections of Diamyd (view press release). Below, FENIX provides highlights and insights into the respective news items.